Ardelyx

-$0.06 (-5.56%) Today

+$0.02 (+1.96%) As of 12:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ardelyx and other ETFs, options, and stocks.

About ARDX

Ardelyx, Inc. is a biopharmaceutical company, which engages in the research, development and commercialization of medicine for the treatment of cardiorenal diseases. Its product portfolio includes tenapanor, which is an experimental medication that works exclusively in the gut and is in late-stage clinical development.

CEO

Michael G. Raab

Employees

129

Headquarters

Fremont, California

Founded

2007

ARDX Key Statistics

Market Cap

105.18M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

4.70M

High Today

$1.08

Low Today

$1.01

Open Price

$1.08

Volume

6.11M

52 Week High

$9.23

52 Week Low

$1.01

ARDX News

Simply Wall StOct 14

Insiders may be rethinking their US$1.0m Ardelyx, Inc. investment now that the company has lost US$19m in value

The recent 14% drop in Ardelyx, Inc.'s ( ) stock could come as a blow to insiders who purchased US$1.0m worth of stock at an average buy price of US$5.89 over t

MarketWatchOct 13

Ardelyx Cuts Staff After Drug-Development Setback

By Matt Grossman Ardelyx Inc. will reduce its workforce to cut costs after a meeting with the U.S. Food and Drug Administration failed to clarify a path forwar

Analyst Ratings

57%

of 7 ratings

Buy

57.1%

Hold

42.9%

Sell

ARDX Earnings

-$0.45

-$0.30

-$0.15

-$0.00

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Actual

Expected Nov 4, Pre-Market